Printed From BioPortfolio.com

Stand Up To Cancer awards Moffitt $2.67M to study lung cancer immunotherapy

12:36 EDT 13 Oct 2017 | CentreWatch

Moffitt Cancer Center was awarded a $2.67 million grant from Stand Up To Cancer (SU2C) to study a possible new immunotherapy for non-small cell lung cancer. This is one of 10 first-of-its-kind grants being awarded by the SU2C Catalyst program. Under the program, pharmaceutical companies donate funds to support collaborative team research using products provided by the companies, such as […]

The post Stand Up To Cancer awards Moffitt $2.67M to study lung cancer immunotherapy appeared first on CenterWatch News Online.

Original Article: Stand Up To Cancer awards Moffitt $2.67M to study lung cancer immunotherapy

More From BioPortfolio on "Stand Up To Cancer awards Moffitt $2.67M to study lung cancer immunotherapy"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Cancer
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches